Abstract |
A total of 122 patients with periarthritis humeroscapularis, tendinitis, and gonarthrosis were accepted into a controlled, randomized double-blind study; of these patients, 61 subjects were administered local infiltrations of thymopentin ( Timunox) 1 ml (50 mg) plus lidocaine 1 ml (2%), once a week for a period of 5 weeks. 61 subjects were during the same time treated with methylprednisolone depot 1 ml (40 mg) plus lidocaine 1 ml (2%). Demographic and clinical parameters were comparable in both groups. Intergroup comparison on completion of the therapy with regard to the criteria " pain at rest", " pain on pressure", "disability of articulation", and " pain relief" revealed statistically significant superiority of thymopentin. No unexpected drug experiences were observed in this double-blind study.
|
Authors | F Pipino, D Vittore |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 38
Issue 1
Pg. 116-9
(Jan 1988)
ISSN: 0004-4172 [Print] Germany |
PMID | 3284530
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Peptide Fragments
- Thymopoietins
- Thymus Hormones
- Thymopentin
- Methylprednisolone
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Arthritis
(drug therapy, physiopathology)
- Female
- Humans
- Male
- Methylprednisolone
(therapeutic use)
- Middle Aged
- Pain
(drug therapy)
- Peptide Fragments
(therapeutic use)
- Periarthritis
(drug therapy, physiopathology)
- Tendinopathy
(drug therapy, physiopathology)
- Thymopentin
- Thymopoietins
(therapeutic use)
- Thymus Hormones
(therapeutic use)
|